Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113684 · ClinicalTrials.gov registry record
Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 175
- Enrollment target
NCT01113684 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 175 participants.
The verdict
NCT01113684 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
Deep brain stimulation (DBS) improves debilitating symptoms of movement disorders when conventional medical therapies and novel surgical therapies fail. Despite the remarkable efficacy of DBS, its therapeutic mechanism remains unclear. There is controversy regarding whether the therapeutic effects of DBS are associated with inhibition or excitation of target neurons, the introduction of new activity into the network, or a combination of these mechanisms. Additionally, it is unclear why stimulus frequency plays an important role in the clinical response to therapy. The fundamental hypothesis of this proposal is that unilateral subthalamic nucleus (STN) DBS in PD alters neuronal activity in the bilateral basal ganglia-thalamic-cortical motor system in a manner that is dependent on stimulation frequency.
Interventions
- DEVICE Implantable pulse generator (deep brain stimulator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01113684
The ClinicalTrials.gov registry entry for NCT01113684 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantable pulse generator (deep brain stimulator) is the first listed.
NCT01113684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01113684 about?
NCT01113684 is a clinical study titled "Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)". Deep brain stimulation (DBS) improves debilitating symptoms of movement disorders when conventional medical therapies and novel surgical therapies fail. Despite the remarkable efficacy of DBS, its therapeutic mechanism remains unclear. There is controversy regarding whether the therapeutic effects o...
What is the current status of trial NCT01113684?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2010-02. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01113684?
The interventions under investigation include: Implantable pulse generator (deep brain stimulator) (DEVICE).
Who is sponsoring clinical trial NCT01113684?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.